Achyut Healthcare to Merge with Zenith Healthcare in Scheme of Amalgamation

Achyut Healthcare to Merge with Zenith Healthcare in Scheme of Amalgamation​

Achyut Healthcare Limited has approved a Scheme of Amalgamation involving its transfer into Zenith Healthcare Limited. The board of directors of Achyut Healthcare made the approval decision on July 14, 2026, following consideration of recommendations from the Audit Committee and the Committee of Independent Directors.

The scheme involves the amalgamation of Achyut Healthcare Limited (the Transferor Company) with Zenith Healthcare Limited (the Transferee Company). This transaction is designed to result in the consequent dissolution of the Transferor Company without winding up and includes the issuance of equity shares by the Transferee Company to the equity shareholders of the Transferor Company as consideration.

The amalgamation, governed by sections 230 to 232 and other applicable provisions of the Companies Act, 2013, is currently subject to necessary statutory and regulatory approvals, including those from the jurisdictional bench of the National Company Law Tribunal (NCLT), as well as shareholder and/or creditor approval.

Financial Snapshot and Business Scope​

The Scheme involves two companies operating in the pharmaceutical sector, each with distinct financial profiles and operational strengths. Both companies share a common promoter group, meaning the transaction is categorized as a related party transaction, though it will be discharged on an arm's length basis. Den Valuation (OPC) Private Limited and Vanshika Vijayvargiy issued a Share Exchange Report based on valuations completed on July 14, 2026.

Key operational and financial details for both entities are provided below:


Achyut Healthcare is currently involved in the trading and dealing of active pharmaceutical ingredients (APIs) and pharmaceutical products. The company is also undertaking the installation and commissioning of a manufacturing facility in Ahmedabad, Gujarat, which adheres to international Good Manufacturing Practice standards, including WHO cGMP certification and EU certification. Zenith Healthcare Limited primarily focuses on the manufacturing, marketing, sale, and export of pharmaceutical products.

Rationale for Amalgamation​

The proposed amalgamation is intended to create synergies and realize long-term value for the shareholders of both companies by leveraging their collective resources. The strategic rationale behind combining the two businesses includes:

• Enhanced Market Reach: Combining will enhance the product portfolios and marketing capabilities, leading to a more comprehensive fulfillment of consumer needs.
• Capacity Optimization: The amalgamation allows for the optimization of manufacturing capacity across the facilities of both companies.
• Efficiency Gains: It will streamline legal and regulatory compliances, reduce overheads, administrative expenditure, and achieve greater economies of scale through combined procurement and distribution networks.
• Strategic Growth: The merger provides an opportunity to unlock new market opportunities in rigorous regulatory markets for the Transferee Company and facilitates a unified balance sheet and increased financial flexibility for future expansion.

Transaction Terms and Shareholding Changes​

Under this Scheme, there is no cash consideration payable. Instead, the Transferee Company will issue fully paid-up Equity Shares of INR 1/- each to the equity shareholders of Achyut Healthcare Limited based on a determined Share Exchange Ratio.

The prescribed Share Exchange Ratio states that for every 50 fully paid-up Equity Shares of Achyut Healthcare Limited held by members recorded in the register, 119 fully paid-up Equity Shares of Zenith Healthcare Limited will be issued.

Pre-amalgamation data shows that Achyut Healthcare holds a total of 24,13,57,000 shares, representing 100% of its equity. Post-amalgamation, the combined entity structure is projected to hold a total of 62,81,68,660 shares.

Stock Price Movement​

As of 11:41, Achyut Healthcare Ltd shares are tracking lower today, currently trading at ₹7.49 after declining by 4.95%.The stock has experienced intraday movement, swinging between a low of ₹7.49 and an earlier peak reaching ₹8.23.